• Contact
  • Join
  • Log In
  • Profile
Canadian Centre for Applied Research in Cancer Control
  • Home
  • About
    • Our Team
    • Funding & Partners
    • FAQ
    • Contact Us
  • Research Areas
    • Research Projects
    • Health Technology Assessment
    • Health Systems, Services, and Policy
    • Societal Values and Public Engagement
    • Survivorship
    • Knowledge Translation
  • News
    • News
    • Funding
    • Jobs/Opportunities
  • Events
    • Events
    • ARCC Conferences
      • ARCC Conference 2021
      • ARCC Conference 2020
      • ARCC Conference 2019
        • Conference Presentations 2019
      • ARCC Conference 2018
        • Conference Presentations 2018
      • ARCC Conference 2017
        • Conference Presentations 2017
      • ARCC Conference 2016
        • Conference Presentations 2016
      • ARCC Conference 2015
        • Conference Presentations 2015
      • ARCC Conference 2014
        • Conference Presentations 2014
      • ARCC Conference 2013
        • Conference Presentations 2013
      • ARCC Conference 2012
        • Conference Presentations 2012
  • ARCC Network
    • Membership List
    • Capacity Building
    • Submission
    • Resources
      • Other Presentations
      • Conference Presentations
        • 2019 Conference Presentations
        • 2018 Conference Presentations
        • 2017 Conference Presentations
        • 2016 Conference Presentations
        • 2015 Conference Presentations
        • 2014 Conference Presentations
        • 2013 Conference Presentations
        • 2012 Conference Presentations
    • Links
  • Search
  • Menu

  • CanREValue Home
  • About Us
    • Our Team
  • Working Groups
    • Planning and Drug Selection Working Group
    • Reassessment & Uptake Working Group
    • Methods Working Group
    • Data Working Group
    • Engagement Working Group
  • Knowledge Translation
  • Resources

In 2017, we received funding from CIHR’s Partnership for Health Systems Improvement  initiative for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) collaboration. This collaboration will develop a framework for the generation and use of Real World Evidence (RWE) for cancer drug funding decisions in Canada.

The CanREValue collaboration brings together key stakeholders including ARCC, CADTH/ pCODR, CAPCA, Health Canada, INESSS, Ministries/departments of Health, pCPA, PMPRB, and provincial cancer agencies from across Canada. By providing a platform for stakeholders to discuss their needs and existing evidence gaps, the CanREValue collaboration will enable knowledge exchange,  and address policy relevant research questions.

Contact us:  CanREValue@cc-arcc.ca

Sign up to receive email updates from CanREValue!

What’s New

Responses to Stakeholder Feedback re: CanREValue Interim Policy Report now available!

0 Comments
/
October 30, 2020
As part of a broader engagement strategy, the CanREValue Collaboration…
https://cc-arcc.ca/wp-content/uploads/2018/07/CanRevalue-logo.jpg 237 872 Rebecca Mercer https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png Rebecca Mercer2020-10-30 11:19:112020-10-30 11:45:44Responses to Stakeholder Feedback re: CanREValue Interim Policy Report now available!

Updated CanREValue Interim Data Report now available!

0 Comments
/
April 21, 2020
As part of a broader engagement strategy, the CanREValue Collaboration…
https://cc-arcc.ca/wp-content/uploads/2018/07/CanRevalue-logo.jpg 237 872 Rebecca Mercer https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png Rebecca Mercer2020-04-21 09:37:222020-04-21 09:37:22Updated CanREValue Interim Data Report now available!

New Publication: Real-world comparative effectiveness of 2nd line ipilimumab for metastatic melanoma...

0 Comments
/
April 16, 2020
ARCC and the CanREValue Collaboration are excited to share our…
https://cc-arcc.ca/wp-content/uploads/2018/07/ARCC_Logo_Horizontal_Lg-linked-in2.jpg 181 354 Rebecca Mercer https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png Rebecca Mercer2020-04-16 10:30:572020-04-16 11:03:17New Publication: Real-world comparative effectiveness of 2nd line ipilimumab for metastatic melanoma...

CanREValue Interim Methods Report Open for Feedback

0 Comments
/
March 23, 2020
The CanREValue Collaboration is pleased to open the feedback…
https://cc-arcc.ca/wp-content/uploads/2018/07/CanRevalue-logo.jpg 237 872 Rebecca Mercer https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png Rebecca Mercer2020-03-23 09:09:582020-03-23 09:09:58CanREValue Interim Methods Report Open for Feedback
Page 1 of 3123

Upcoming Events

2021 ARCC Conference
May 17, 2021 

RECENT POSTS

  • Canadian Partnership Against Cancer logoCPAC Hiring: Lead Cancer Analyst, AnalyticsFebruary 25, 2021 - 11:11 am
  • Request for EOI: Assessing the safety and effectiveness of current and future SARS-CoV-2 vaccines deployed in CanadaFebruary 9, 2021 - 8:10 am
  • Recruiting: Research Communications Manager, Canadian Cancer SocietyFebruary 8, 2021 - 2:10 pm
  • Canadian Partnership Against Cancer logoCPAC recruiting Expert Advisors for OncoSim Breast & OncoSim All-Cancer Working GroupsJanuary 27, 2021 - 10:26 am

Login Status

Forgot?  Register
© Copyright - Canadian Centre for Applied Research in Cancer Control - Website by North Studio
Scroll to top
Translate »